Worldwide Clinical Laboratory Testing Market

SUMMARY

Diagnostic tests or clinical laboratory tests have a very important role in the diagnosis of any disease and in the healthcare system. These tests are the basis of most of the medical decisions. The laboratory tests are mainly of three types, clinical or routine tests, anatomic pathology tests and esoteric tests. Diagnostics tests have a little wider coverage than the clinical laboratory tests.

Payors play an important role in this industry as they are the ones who reimburse the cost of the tests to the laboratories. There are both government and private payors and include healthcare insurers also. Each of these payors operates differently and also have different share in the reimbursements depending upon the countries. The laboratory testing industry is also supported by the In Vitro Diagnostic industry which supplies all the instruments used in the laboratory tests.

International Laboratory Accreditation Cooperation (ILAC) is the international body for accrediting these laboratories. Each country or region has an independent accrediting body which is ultimately a member of or affiliated to the ILAC, to provide accreditation to the laboratories.

With the increasing awareness about early detection and prevention of diseases and the aging of the world population, the industry is poised for rapid growth. There are various players in this industry. Most players are limited to a country or a region but a few operate more widely. For example, Quest Diagnostic and LabCorp in USA, LAbco Diagnostics in Europe, Sonic Healthcare (SHL), Symbion Health, and Healthscope (HSP) in Austraila.

This report analyzes the global clinical laboratory market and various aspects of the market like reimbursement market and In Vitro Diagnostic market. It has also covers various countries and the respective markets, their issues and growth drivers. The report also profiles the leading players of this industry.

TABLE OF CONTENTS

1. Clinical Laboratory Testing: An Overview

• 1.1 Routine Tests
• 1.2 Anatomic Pathology Tests
• 1.3 Esoteric Tests

2. Market Size

• 2.1 European Market
  • 2.1.1 Market Value by Segments
  • 2.1 2 Market Value by Region
• 2.2 US Market
  • 2.2.1 Market Growth
  • 2.2.2 Market Segments
  • 2.2.3 Market Share
• 2.3 Australian Market
  • 2.3.1 Market Share
• 2.4 New Zealand
  • 2.4.1 Market Share

3. Reimbursements

• 3.1 US Market
  • 3.1.1 Medicare
  • 3.1.2 Medicaid
  • 3.1.3 Healthcare Insurers
• 3.2 New Zealand and Australia

4. Market Features

• 4.1 Accreditation System
• 4.2 Growth Drivers
  • 4.2.1 Ability to Leverage Database Information
  • 4.2.2 Shift to Preventive Medicine
  • 4.2.3 Demographic Trends
  • 4.2.4 Increase in Cancer Survival and Incidence Rates
  • 4.2.5 Cost Effectiveness of Laboratory Testing
  • 4.2.6 Emergence of Point-of-Care (POC) Testing
  • 4.2.7 Personalized Medicine
• 4.3 Market Issues
  • 4.3.1 Cross Border Delivery of Clinical Laboratory Services
  • 4.3.2 Reimbursement Risk from Government and Managed Care Payors

5. Company Profiles

• 5.1 Quest Diagnostics
  • 5.1.1 Overview
  • 5.1.2 Business Strategies
  • 5.1.3 Leading Medical Innovation & IT Solutions
  • 5.1.4 Attracting Patients with Superior Services
• 5.2 Laboratory Corp. of America
  • 5.2.1 Overview
  • 5.2.2 Business Strategies
  • 5.2.3 Differentiation Drives Growth
  • 5.2.4 Managed Care Partnerships
  • 5.2.5 Customer Retention through Exceptional Service
• 5.3 Healthscope
  • 5.3.1 Overview
  • 5.3.2 Business Strategies
  • 5.3.3 Restructuring through Acquisitions & Disposals
  • 5.3.4 Shareholder Communication Strategy
• 5.4 Sonic Healthcare
  • 5.4.1 Overview
  • 5.4.2 Business Strategies
  • 5.4.3 Medical Management and Leadership

List of Tables

• European Diagnostic Testing Scenario
• Growth Rates of Test Types in US

List of Charts

• Types of Clinical Tests
• Europe Clinical Diagnostics Market by Segments (2007)
• European Clinical Laboratory Market by Region (2006)
• US Diagnostic Laboratory Testing Market by Segment (2006)
• US Diagnostic Laboratory Testing Market Share (2006)
• Australia - Growth in Medicare Outlays (2000-06)
• Market Share of Australian Private Pathology Market (2006)
• Market Share of New Zealand Pathology Market (2006)
• Payors Breakup in US Clinical Laboratory Market (2006)
• Sales and Assets Growth of Quest Diagnostic (2003-07)
• Sales and Assets Growth of LabCorp (2003-07)
• Sales and Assets Growth of Healthscope (2003-07)
• Sales and Assets Growth of Sonic Healthcare (2003-07)